(MENAFN- GlobeNewsWire - Nasdaq) The market currently prioritizes AI-driven precision and hybrid imaging solutions. Rapid FDA approvals for automated tools and high-performance trolley systems indicate a shift towards minimizing operator error while expanding diagnostic capabilities across diverse clinical settings.

Chicago, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The global diagnostic ultrasound market was valued at US$ 8.4 billion in 2024 and is expected to reach 12.4 billion by 2033, growing at a CAGR of 4.4% throughout the forecast period of 2025–2033.

The current demand trajectory for diagnostic ultrasound market is fundamentally shifting from a hardware-centric procurement model to an efficiency-driven software ecosystem. In mature markets like North America and Europe, the primary catalyst is no longer just clinical capability but the urgent need to decouple imaging volume from severe labor constraints. With sonographer vacancy rates forcing operational bottlenecks, hospital C-suites are prioritizing premium systems offering AI-automated measurements that reduce exam times by 30-40%. Consequently, capital allocation is aggressively flowing toward "smart" devices that allow lower-level practitioners to capture billing-grade images, effectively expanding the user base beyond radiology.

Request Sample Pages:

Simultaneously, the outpatient sector is emerging as a critical revenue engine. Office-Based Labs (OBLs) and Ambulatory Surgery Centers (ASCs) are accelerating purchases of high-frequency vascular and MSK probes to capitalize on favorable reimbursement codes for peripheral interventions, bypassing the overhead of acute care settings. In contrast, demand in developing economies is anchored by large-scale government modernization tenders, where durability and throughput take precedence over advanced features. Stakeholders must recognize that the market is bifurcating: value is driven by workflow automation in the West and pure volume expansion in the East, with the "app-ification" of ultrasound converting one-time hardware sales into recurring software revenue streams.

Key Findings in Diagnostic Ultrasound Market

Market Forecast (2033)	US$ 12.4 Billion
CAGR	4.4%
Largest Region (2024)	North America (31.95%)
By Technology	2D (36.55%)
By Portability	Trolley (67.86%)
By Application	Obstetrics/Gynecology (Largest)
Top Drivers	Rising chronic disease prevalence necessitates early non-invasive diagnostic tools. Integration of Artificial Intelligence enhances imaging accuracy and workflow speed. Growing demand for point-of-care devices expands access in remote areas.
Top Trends	Fusion imaging combines ultrasound with CT/MRI for comprehensive visualization. Handheld devices becoming wireless and connecting to smartphones for mobility. Cloud-based image sharing enables remote interpretation and tele-ultrasound services.
Top Challenges	Stringent regulatory hurdles delay approval for advanced AI-integrated systems. Variability in operator expertise affects image quality and diagnostic accuracy. Data security concerns arise with increasing cloud-based storage adoption.

Ultra-Portable Hardware Innovations Revolutionize Clinical Capabilities In Medical Imaging

Hardware evolution defines the current Diagnostic ultrasound market landscape in 2024. Butterfly Network launched the iQ3 in February 2024 with a probe face 17% smaller than prior models. The design specifically aids intercostal access. The system charges 2.5 times faster than its predecessor. Philips Lumify transducers now weigh under 136 grams for ultimate portability. GE HealthCare's Vscan Air SL supports 50 minutes of continuous scanning. Such metrics prove the industry's intense focus on miniaturization. Clinicians now carry hospital-grade imaging power in their pockets. Manufacturers are successfully shrinking footprints while expanding capabilities.

Performance in compact forms drives widespread adoption. Clarius Mobile Health's PAL HD3 scanner covers a frequency range of 1 MHz to 15 MHz. The device achieves imaging depths up to 40 cm without switching probes. Canon Medical's Aplio me system fits into a width of just 55 cm. These engineering feats push the Diagnostic ultrasound market forward. Clinicians demand diagnostic power in small packages for bedside assessments. The shift toward "chip-on-probe" architectures enables these massive reductions in size. Every millimeter shed from a device represents a leap in usability for frontline workers.

Artificial Intelligence Integration Drastically Reduces Workflows and Manual Exam Times

Efficiency is paramount in the modern Diagnostic ultrasound market. Siemens Healthineers' Acuson Sequoia 3.5 reduces sonographer hand motion by 89% per exam. The system's "AI Abdomen" feature cuts protocol time by 44%. Automation recognizes 17 distinct anatomical views without user input. It also calculates 12 key clinical measurements instantly. Such features address critical time constraints in hospitals. AI is no longer theoretical; it is a functional requirement for high-volume centers. Reducing physical strain and exam duration improves staff retention. Hospitals are actively seeking these automated solutions.

Operational gains translate directly to financial success. Wellstar MCG Health saw a 47% revenue capture increase after deploying Exo Works workflow software. QA review rates jumped from 10% to 100% post-implementation. The facility achieved an ROI of 203% within nine months. Wellstar also reduced billing time to mere seconds. AI is reshaping the Diagnostic ultrasound market economics by fixing revenue leaks. Administrators prioritize software that guarantees payment for services rendered. The correlation between AI adoption and revenue recovery is now undeniably proven.

Leading Corporations Report Massive Revenue Streams and R&D Expenditure Spikes

Financial reports from 2024 reveal the Diagnostic ultrasound market strength. GE HealthCare generated US$ 824 million in Q1 2024 ultrasound revenue. Q2 2024 figures remained steady at US$ 823 million. The company boosted R&D spending to US$ 324 million in Q1. Philips reported Group sales of EUR 18.0 billion for the fiscal year. Ultrasound contributed significantly to the EUR 8.8 billion Diagnosis & Treatment segment. These expenditures indicate a belief in sustained sector growth. Corporations are reinvesting profits rapidly to maintain technological leadership.

Growth extends globally across major conglomerates. Mindray recorded total revenue of approximately EUR 4.90 billion in 2024. Their international growth hit 30% in Q1. Mindray's high-end ultrasound models grew by over 25% within their portfolio. Philips noted that 19% of Precision Diagnosis sales came specifically from ultrasound. These numbers confirm the Diagnostic ultrasound market as a profit center. Capital is flowing into research to develop the next generation of scanners. The financial health of these key players underpins the entire industry's stability.

Regulatory Bodies Rapidly Clear Advanced Software and Hardware For Commercial Use

Approvals in 2024 accelerated Diagnostic ultrasound market accessibility. EndoSound received FDA 510(k) clearance on January 3, 2024. Butterfly Network secured clearance for iQ3 on January 8, 2024. Clarius obtained approval for "Bladder AI" on January 15, 2024. Regulators are moving fast to validate new tools. Exo secured its 5th FDA clearance by April 2024. These rapid approvals signal a supportive regulatory environment. Government bodies are prioritizing the release of advanced diagnostic tools. The pace of clearance matches the speed of innovation.

Strategic alliances also bolster compliance and market entry. Canon Medical aligned with Olympus in January 2024 to enhance endoscopic offerings. Samsung Medison's subsidiary Sonio holds FDA clearance for "Sonio Detect". Siemens Healthineers received clearance for the updated Acuson Sequoia 3.5 in late 2024. These milestones ensure the Diagnostic ultrasound market remains compliant and safe. Rapid clearances facilitate faster product launches. Manufacturers are successfully navigating complex regulatory pathways to bring AI-enhanced devices to patients. The regulatory landscape in 2024 is an enabler of growth rather than a bottleneck.

Intense Competition and Strategic Acquisitions Define the Handheld Device Sector

Pricing strategies are aggressive in the Diagnostic ultrasound market. Butterfly Network priced the iQ3 at US$ 3,899. GE HealthCare markets the Vscan Air SL around US$ 4,800. Philips offers Lumify subscriptions starting at US$ 199 monthly. Clarius shipped over 25,000 handheld systems by March 2024. The company now serves users in 58 countries. Low barriers to entry are democratizing access. Clinicians can now afford personal imaging devices. Market penetration is deepening as costs decrease.

Acquisitions fuel market consolidation and capability expansion. Samsung Medison acquired Sonio for US$ 92.7 million in May 2024. PacifiCan invested CAD 3.4 million in Clarius to boost exports. Mindray now holds a top 3 global ranking. Clarius ranked #2 in Fast Company's innovation list. Butterfly expanded to 15 European markets in September 2024. Competition drives the Diagnostic ultrasound market innovations. Smaller players are being absorbed or funded to scale rapidly. Fujifilm Sonosite launched the ST system with a 21-inch touchscreen to compete. The battle for market share is resulting in better technology for end-users.

Workforce Shortages and Aging Demographics Necessitate Automated Imaging Solutions

Workforce gaps drive Diagnostic ultrasound market technology adoption. The UK Society of Radiographers reports a 14.9% vacancy rate. Only 1,945 FTE sonographers are currently in post there. 29% of that workforce is near retirement. US open positions jumped 36.3% over the last decade. Graduates increased only 23% in that timeframe. The disparity between supply and demand is critical. Hospitals simply cannot hire enough staff to meet patient needs. Technology must fill the void left by retiring professionals.

Demand for exams continues to rise despite staff shortages. US volumes hit 59.8 million annually in 2024. 50% of physicians believe POCUS will be mainstream within five years. Hospitals need automated tools to bridge the gap. The Diagnostic ultrasound market offers solutions to these labor crises. Automation creates a path forward for overwhelmed staff. Systems that require less training are becoming the standard. The industry is pivoting to support a less specialized workforce through intelligent design.

Engineering Breakthroughs Deliver Superior Battery Life and Image Clarity

Technical specs in 2024 set new Diagnostic ultrasound market standards. Butterfly iQ3 uses "Ultrasound-on-Chip" to double data transfer rates. Canon Aplio me offers 4 hours of battery autonomy. The system operates at a quiet 31.7 dB. Siemens Acuson Sequoia 3.5 features a lightweight HLX transducer. Engineers prioritize user comfort and device endurance. High data rates ensure real-time clarity during procedures. Silence and longevity allow for uninterrupted clinical focus.

Software updates enhance hardware capabilities continuously. Clarius launched App version 12.0 in January 2025. Fujifilm Sonosite ST boasts a 10 by 7.5-inch image area. Konica Minolta's L18-4 probe uses nanofabrication for broad frequency imaging. These metrics attract buyers seeking high performance. The Diagnostic ultrasound market thrives on such verifiable technical improvements. Buyers compare these specifications rigorously before purchase. Superior engineering translates to better diagnostic confidence. Innovation is measured in decibels, minutes of battery, and pixel density.

Need a Customized Version? Request It Now:

Government Initiatives and Renewal Programs Fuel Large Scale Capital Investments

State funding powers the Diagnostic ultrasound market in Asia. Guangdong Province announced a US$ 745 million equipment renewal plan. The initiative targets 2,171 new medical devices. Fujian Province allocated US$ 105 million for 179 equipment sets. China aims to increase investment by 25% by 2027. Such policies guarantee sustained demand. Governments are stepping in to modernize healthcare infrastructure. These large-scale tenders provide stability for manufacturers. The renewal cycle is a massive opportunity for revenue.

Utilization rates justify these investments in modern equipment. Clarius scanners facilitated 4 million scans by 2024. 68% of POCUS exams are documented. Yet only 50% are billed successfully. 79% of users say AI would improve usage. Philips gains 24% of sales from circular revenues. The Diagnostic ultrasound market is pivotal for future healthcare infrastructure. Refurbished systems also play a key role in the ecosystem. Utilization data proves that once devices are purchased, they are heavily used. The market is vibrant, active, and essential for patient care.

Diagnostic Ultrasound Market Major Players:

• Canon Medical Systems Corporation
• Esaote S.P
• GE GealthCare Technologies Inc.
• Hologi Inc.
• Konica Minolta Inc.
• Koninklijke Philips N.V.
• Samsung Electronics Co. Ltd.
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Mindray Medical International Limited
• KronosMD Inc.
• Other Prominent Players

Key Market Segmentation:

By Technology

• 2D
• 3D and 4D
• Doppler

By Portability

• Trolley
• Compact/Handheld

By Application

• General Imaging
• Cardiology
• Obstetrics/Gynecology
• Others

By End-use

• Hospitals
• Maternity Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

Need a Detailed Walkthrough of the Report? Request a Live Session:

About Astute Analytica

Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements.

With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace.

Contact Us:
Astute Analytica
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
For Sales Enquiries: ...
Website:
Follow us on: LinkedIn Twitter YouTube

CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries:... Website:

MENAFN03122025004107003653ID1110431452